Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Carcinoma, Ovarian Epithelial 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sezary Syndrome 2Neoplasm Metastasis 2Mycosis Fungoides 2Melanoma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms, Male 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Testicular Neoplasms 1Somatostatinoma 1Small Cell Lung Carcinoma 1

Interventions

Cyclophosphamide 16aldesleukin 14fludarabine 12fludarabine phosphate 11Interleukin-2 10montanide ISA 51 3Whole-Body Irradiation 2Radiation 2MART-1 Antigen 2Gefitinib 2sargramostim 1pembrolizumab 1peginterferon alfa-2a 1incomplete Freund's adjuvant 1flt3 ligand protein 1endonuclease V, phage T4 1Surgical Procedures, Operative 1Semaxinib 1Radiotherapy 1Peptides 1Lapatinib 1Interleukin-15 1Interleukin-12 1Early Intervention, Educational 1Deoxyribonuclease (Pyrimidine Dimer) 1Dasatinib 1Congresses as Topic 1Cholecalciferol 1B3(Fv)-PE38KDEL recombinant immunotoxin 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Skin Neoplasms × Interleukin-12 × Clear all
NCT00019188 2024-03-04

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 1/2 Completed
DermatologicSarcoma

AIDS-related Kaposi sarcoma, Neoplasms, Sarcoma, Kaposi, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡